by Shreesha V | Jul 17, 2024 | News
The AMT-130 Study An Exciting development in the Huntington’s research space. uniQure has released encouraging interim results from the AMT-130 therapy trials for Huntington’s Disease (HD). Since the trials began, AMT-130 has faced some challenges. Initial...
by Shreesha V | Jul 16, 2024 | News
SELECT-HD Trial Update A promising step forward for the Huntington’s Disease Community Wave Life Sciences Ltd. recently announced positive results from their SELECT-HD trial (NCT05032196), a global multicenter, double-blind, placebo-controlled, Phase 1b/2a...
by Shreesha V | Jul 15, 2024 | News
Information and Awareness Newsletter July 2024 Welcome to the July edition of our newsletter! In this issue, we delve into the various factors influencing decision-making regarding predictive testing and offer practical ways to support a loved one preparing for such a...
by Shreesha V | Jun 17, 2024 | News
A news update from SAGE therapeutics !! We are excited to announce ground-breaking results from SURVEYOR, a clinical trial focused on cognitive changes in individuals with Huntington’s disease (HD). This trial tested the short-term safety and efficacy of...
by Shreesha V | Jun 11, 2024 | News
Information sheet: Understanding Genetic Counselling We are excited to announce a new resource available on the Huntington’s Victoria website: an information sheet on genetic counselling, drafted in collaboration with Sachini Poogoda, an Associate Genetic...
(03) 9818 6333 / 1800 063 501 (Toll Free)
